ODYSSEY MARINE EXPLORATION (OMEX)       3.19  +0.18 (+5.98%)

3.19  +0.18 (+5.98%)

US6761182012 - Common Stock


Fundamental Rating

Taking everything into account, OMEX scores 0 out of 10 in our fundamental rating. OMEX was compared to 97 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of OMEX have multiple concerns. OMEX is valued expensive and it does not seem to be growing.

Note: OMEX has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating


OMEX has negative profitability rations, so we won't be analyzing them here.
OMEX's Return On Assets of -161.32% is worse than the rest of the industry. The industry average Return On Assets is 0.77%. 99% of the industry peers have a better Return On Assets.

OMEX has a Profit Margin of -1556.92%. This is below the industry average of 0.87%. 99% of the industry peers outperform OMEX.
The Piotroski-F score of OMEX is 1.00. This is a very weak score and indicates problems in health and profitability for OMEX.
VS Industry

ROA (-161.32%) VS Industry: 1% outperformed.

-185.11
19.88

Profit Margin (-1556.92%) VS Industry: 1% outperformed.

-7,721.47
48.60

Valuation

Valuation Rating


OMEX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

VS Industry

Growth

Growth Rating


The Earnings Per Share has grown by an impressive 26.73% over the past year.
OMEX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -29.61%.

Measured over the past 5 years, OMEX shows a very negative growth in Revenue. The Revenue has been decreasing by -27.75% on average per year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A 26.73% N/A N/A N/A N/A
Revenue-27.75% -34.51% -29.61% N/A N/A N/A N/A

Health

Health Rating


OMEX has a Current Ratio of 0.05. This is a bad value and indicates that OMEX is not financially healthy enough and could expect problems in meeting its short term obligations.
When comparing the Current Ratio of OMEX to the average industry Current Ratio of 1.50, OMEX is less able to pay its short term obligations than its industry peers. 100% of its industry peers have a better Current Ratio.
OMEX has a Quick Ratio of 0.05. This is a bad value and indicates that OMEX is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Quick Ratio of 1.25, OMEX is worse placed to pay its short term obligations than its industry peers. 100% of its industry peers have a better Quick Ratio.

OMEX has a negative Debt to Equity ratio (-0.57), which implies it has negative shareholder equity as the company's liabilities exceed its assets. This could be considered a sign of high risk.
Based on the Altman-Z score of -54.61, we must say that OMEX is in the distress zone and has some risk of bankruptcy.
When comparing the Altman-Z score of OMEX to the average industry Altman-Z score of 2.00, OMEX is less financially healthy than its industry peers. 100% of its industry peers have a better Altman-Z score.
OMEX has a very weak Piotroski-F score of 1.00. This is an indication of health and profitability issues for OMEX.
VS Industry

Quick Ratio (0.05) VS Industry: 0% outperformed.

0.05
44.95

Current Ratio (0.05) VS Industry: 0% outperformed.

0.05
44.95

Altman-Z (-54.61) VS Industry: 0% outperformed.

-54.61
19.82

Dividend

Dividend Rating


OMEX does not give a dividend.

OMEX Daily chart

ODYSSEY MARINE EXPLORATION3.19

NASDAQ:OMEX (8/16/2022, 7:00:02 PM)+0.18 (+5.98%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Commercial & Professional Services
GICS Industry Commercial Services & Supplies
Earnings (Last) 06-07 2022-06-07/amc Earnings (Next) 08-23 2022-08-23/bmo
Ins Owners 0.01% Inst Owners 29.79%
Market Cap 61.97M Analysts 82.86
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S 66.7 P/B N/A
EV/EBITDA -5.4
Profitability
ROA -161.32% ROE N/A
PM -1556.92 Asset Turnover 0.1
Growth
EPS 1Y 26.73% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q -94.2%
EPS Next Y N/A EPS Next 2Y N/A
EPS Next 3Y N/A EPS Next 5Y N/A
Revenue growth 1Y -29.61% Revenue growth 3Y -34.51%
Revenue growth 5Y -27.75% Revenue growth Q2Q 3.31%
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
Health
Current Ratio 0.05 Quick Ratio 0.05
Altman-Z -54.61 F-Score 1
Debt/Equity -0.57
Dividend
Dividend Yield N/A Dividend Growth N/A
DP 0% Ex-Date N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA